Stem Cell Research
The Issue
One of the most promising areas of research in medical science today is the potential to use stem cells to better understand diseases and find treatments and cures. This research has become controversial because it involves the use of human embryos.
Our Position
Massbio opposes the use of cloning technology for the purpose of initiating and bringing to term a human pregnancy, commonly called human cloning.
We support therapeutic cloning, which is the use of cloning of human cells, genes and tissues for the purpose of medical research and for the treatments of such conditions as Parkinson's, multiple sclerosis, diabetes and spinal cord injuries.
We support President Obama's decision to overturn the federal stem cell funding ban in order to solve unmet medical needs around the globe.
About MassBio
MassBio is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.
Founded in 1985, MassBio represents over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, and works to advance policy and promote education, while providing member programs and events, industry information, and services.
Latest Updates
- September 2, 2010 The Massachusetts STEM Plan: A Summit Mapping the Commonwealth's STEM Future
- August 24, 2010 MassBio Statement on Stem Cell Decision
- August 18, 2010 NEU's new weight-loss compound shows promise
- August 18, 2010 TraceLink Partners with Patheon to Optimize Life Science Contract Manufacturing Performance
- August 17, 2010 Lucille C. Servidio Appointed to Board of Directors for CMBEN